HCID 10131699, compound → HCID 68610298, compound
Reaction equation
F[C:2]1[CH:3]=[C:4]([CH2:9][C@H:10]([NH:14][C:15](=[O:24])OCC2C=CC=CC=2)[C@H:11]2[CH2:13][O:12]2)[CH:5]=[C:6](F)[CH:7]=1.[CH3:25][O:26][C:27]1[CH:36]=[C:35]2[C:30](CCC[CH:34]2[NH2:37])=[CH:29][CH:28]=1.C(N(CCC)C([C:44]1[CH:45]=[C:46]([CH:50]=[C:51](CC)[CH:52]=1)C(O)=O)=O)CC>>[CH2:9]([C@H:10]([NH:14][C:15](=[O:24])[C:52]1[CH:44]=[CH:45][C:46]([NH:14][CH2:10][CH2:9][CH2:4][CH3:3])=[CH:50][CH:51]=1)[C@H:11]([OH:12])[CH2:13][NH:37][CH2:34][C:35]1[CH:30]=[CH:29][CH:28]=[C:27]([O:26][CH3:25])[CH:36]=1)[C:4]1[CH:3]=[CH:2][CH:7]=[CH:6][CH:5]=1Participants
4
Procedure
Following the general procedure of EXAMPLEs 4, 5 and 6 and making non-critical variations but using tert-butyl 1-(2-oxiranyl)-2-phenylethylcarbamate (V), 3-methoxybenzylamine (VI) and 4-(butylamino)benzoic acid (IX), the title compound is obtained, MR+=476.
Sources & evidence
- ORD record
- ord-49a36eb3d14c4505985ef96002928f0a
- Source dataset
- uspto-grants-2007_05
- Patent number
- US07214715B2
Reaction notes
Loading…